Christian Schulze Presents The Post-Hoc Analysis of the DanGer Shock Trial
Christian Schulze, Professor of Medicine at Friedrich-Schiller-University Jena, shared on LinkedIn:
”Escalation of Mechanical Circulatory Support in Patients with STEMI-related Cardiogenic Shock: A post-hoc Analysis of the DanGer Shock Trial.
Escalation to tMCS occurred in almost 1/5 patients, was more likely in the control group, and was associated with a higher mortality risk.
Even with early escalation (<1 hour), patients escalated from the control group had the highest mortality, underscoring the need for future trials to define optimal escalation strategies.”
Read the full article here.
Article: Escalation of Mechanical Circulatory Support in Patients with STEMI-related Cardiogenic Shock: A post-hoc Analysis of the DanGer Shock Trial
Authors: Benedikt Schrage; Rasmus Paulin Beske; Christian Hassager; Lisette Okkels Jensen; Hans Eiskjær; Norman Mangner; Amin Polzin; P Christian Schulze; Carsten Skurk; Peter Nordbeck; Vasileios Panoulas; Sebastian Zimmer; Andreas Schäfer; Nikos Werner; Thomas Engstrøm; Lene Holmvang; Nanna Louise Junker Udesen; Henrik Schmidt; Anders Junker; Christian Juhl Terkelsen; Steffen Christensen; Axel Linke; Dirk Westermann; Peter Clemmesen; Jacob Eifer Møller
Stay updated on all scientific advances with Hemostasis Today.
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers
-
May 12, 2026, 15:21Joseph Mmwa: Blood Donation Debate Sparks Concern Across Kenya
-
May 12, 2026, 15:20Wolfgang Miesbach: Roctavian Experience in Modern Hemophilia Gene Therapy
-
May 12, 2026, 15:16Abdul Mannan: Acquired Haemophilia A after Tozinameran
-
May 12, 2026, 15:14Jim Hoffman: Persistent EBV Infection and the Promise of NET-Targeted Treatment